Abstract:Highlight • The effective integration of machine learning and genetic algorithms to optimize peptide modifications offers a promising avenue for peptide design. • It introduces novel techniques for the directly modification of small peptides, particularly in cases where insufficient data is available for traditional approaches. • It strategically positions the introduction of positive charge amino acids via our model instead of a mere cumulative addition of positive charged amino-acids. • Minimal modifications to the peptide structure can exert a profound influence on the inhibitory activity of LPS-binding peptides. Introduction Antimicrobial peptides (AMPs) are valuable alternatives to traditional antibiotics, possess a variety of potent biological activities and exhibit immunomodulatory effects that alleviate difficult-to-treat infections. Clarifying the structure-activity relationships of AMPs can direct the synthesis of desirable peptide therapeutics. Objectives In this study, the lipopolysaccharide-binding domain (LBD) was identified through machine learning-guided directed evolution, which acts as a functional domain of the anti-lipopolysaccharide factor family of AMPs identified from Marsupenaeus japonicus . Methods LBD A-D was identified as an output of this algorithm, in which the original LBD Mj sequence was the input, and the three-dimensional solution structure of LBD B was determined using nuclear magnetic resonance. Furthermore, our study involved a comprehensive series of experiments, including morphological studies and in vitro and in vivo antibacterial tests. Results The NMR solution structure showed that LBD B possesses a circular extended structure with a disulfide crosslink at the terminus and two 3 10 -helices and exhibits a broad antimicrobial spectrum. In addition, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that LBD B induced the formation of a cluster of bacteria wrapped in a flexible coating that ruptured and consequently killed the bacteria. Finally, coinjection of LBD B , Vibrio alginolyticus and Staphylococcus aureus in vivo improved the survival of M. japonicus , demonstrating the promising therapeutic role of LBD B for treating infectious disease. Conclusions The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics. Graphical abstract Download : Download high-res image (110KB) Download : Download full-size image Employing machine learning and genetic algorithms, we developed structurally enhanced antimicrobial peptides boasting exceptional efficacy.

Bactericidal Peptide Targeted Against Penicillin/Methicillin-resistant Staphylococcus Aureus--an Engineered Multidomain Protein Machine

An Engineered Multidomain Bactericidal Peptide As a Model for Targeted Antibiotics Against Specific Bacteria

Potential Therapeutic Efficacy of a Bactericidal–immunomodulatory Fusion Peptide Against Methicillin-Resistant Staphylococcus Aureus Skin Infection

Targeted and Intracellular Antibacterial Activity against S. agalactiae of the Chimeric Peptides Based on Pheromone and Cell-Penetrating Peptides

Hybrid Antimicrobial Peptide Targeting<i>Staphylococcus aureu</i>s and Displaying Anti-infective Activity in a Murine Model

Triple-acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus

An Engineered Multidomain Fungicidal Peptide Against Plant Fungal Pathogens.

Engineering hybrid lantibiotics yields the highly stable and bacteriocidal peptide cerocin V

Design, Overproduction and Purification of the Chimeric Phage Lysin MLTphg Fighting against Staphylococcus aureus

Repurposing a drug targeting peptide for targeting antimicrobial peptides against Staphylococcus

Efficacy of Antimicrobial Peptide DP7, Designed by Machine-Learning Method, Against Methicillin-Resistant Staphylococcus Aureus.

Phage‐displayed Heptapeptide Sequence Conjugation Significantly Improves the Specific Targeting Ability of Antimicrobial Peptides Against Staphylococcus Aureus

Conversion of Broad-Spectrum Antimicrobial Peptides into Species-Specific Antimicrobials Capable of Precisely Targeting Pathogenic Bacteria.

Bactericidal Efficiency and Mechanism of Specifically Targeted Antimicrobial Peptides Optimized Based on Structural and Functional Relationships

A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus Aureus in Keratinocytes and Has Potential As a Treatment for Skin Infections in Mice

Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides

Self-Assembling and Pore-Forming Peptoids as Antimicrobial Biomaterials

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus

The Molecular Design of a Recombinant Antimicrobial Peptide CP and Its in Vitro Activity

Bactericidal Activity of Constructed Recombinant Fusion Protein Pheromonicin-CT